Breaking Down Innuovo Technology Co., Ltd. Financial Health: Key Insights for Investors

Peeling back the numbers behind Innuovo Technology Co., Ltd. (000795.SZ) reveals a mixed financial picture that investors should scrutinize: operating revenue for the first three quarters of 2025 fell to CNY 2.727 billion (down 9.87% YoY) while net profit attributable to shareholders stood at CNY 201 million (down 3.16% YoY) with diluted EPS of CNY 0.183 and net profit after non-recurring items at CNY 159 million (down 17.40%); profitability shows a 24.1% gross profit margin, a 7.4% net profit margin and ROE of 9.11%, while margins such as operating (6.41%) and EBITDA (8.20%) have contracted; the balance sheet and liquidity picture is relatively solid with total equity of CNY 2.7 billion versus total debt of CNY 266.92 million (debt-to-equity 9.85%), cash and equivalents of CNY 555.09 million, a current ratio of 2.16, operating cash flow of CNY 411.36 million and net cash position of CNY 488.17 million as of September 30, 2025; valuation metrics as of December 5, 2025 show a market cap of CNY 10.88 billion, P/E of 45.13 and P/B of 4.16, alongside a modest dividend yield of 1.39%; key risks include revenue and margin declines and lower operating cash flow, yet the company is pursuing growth via a strategic expansion-an approved 5,000-ton sintered NdFeB magnet project with ~CNY 424 million investment expected to complete within 18 months from June 27, 2025-an initiative that could reshape future capacity and market positioning for rare-earth permanent magnets.

Innuovo Technology Co., Ltd. (000795.SZ) - Revenue Analysis

• Operating revenue (1-3Q 2025): CNY 2,727.0 million, down 9.87% YoY.
• Operating revenue (1H 2025): CNY 1,734.0 million, down 14.73% YoY.
• Net profit attributable to shareholders (1-3Q 2025): CNY 201.0 million, down 3.16% YoY.
• Net profit (1H 2025): CNY 144.0 million, up 0.52% YoY.
• Net profit after deducting non-recurring gains/losses (1-3Q 2025): CNY 159.0 million, down 17.40% YoY.
• Basic earnings per share (latest reported): CNY 0.183.

• Revenue decline moderates between mid-year and 3Q: 1H decline of 14.73% vs. 9.87% for the first nine months, implying a recovery in 3Q revenue run-rate relative to 1H.
• Net profit resilience: despite revenue pressure, net profit attributable fell only 3.16% for 1-3Q, supported by cost control, margin recovery, or non-operating items in the period.
• Recurring profitability under pressure: recurring net profit declined 17.40% YoY, indicating one-off items partly insulated reported net income.
• EPS at CNY 0.183 reflects modest per-share earnings amid top-line contraction; investors should track quarterly cadence for EPS trajectory.

Innuovo Technology Co., Ltd. (000795.SZ) - Profitability Metrics

For the first three quarters of 2025, Innuovo Technology's core profitability indicators show moderate gross margins with compressed net margins, indicating pressure from operating costs, financing or non-operating items. Key headline metrics are summarized below and followed by brief implications for investors.

• Margin profile: 24.1% gross margin vs. 7.4% net margin indicates non-COGS expenses (SG&A, R&D, interest, tax) materially reduce bottom-line.
• Operating leverage: 6.41% operating margin and 8.20% EBITDA margin suggest depreciation/amortization is modestly impacting operating profitability.
• Capital efficiency: ROE of 9.11% with ROA of 2.74% implies leverage is amplifying returns to equity; examine debt levels and interest burden.

Key numeric snapshot (Q1-Q3 2025):

• Investors should monitor trends in gross margin (product mix and input costs), SG&A and R&D spend (affecting operating margin), and interest/one-off items (affecting net margin).
• Improving asset turnover or reducing low-return assets could lift ROA and, if financed efficiently, improve ROE.

Additional corporate orientation and strategic context can be found here: Mission Statement, Vision, & Core Values (2026) of Innuovo Technology Co., Ltd.

Innuovo Technology Co., Ltd. (000795.SZ) - Debt vs. Equity Structure

As of September 30, 2025, Innuovo Technology's balance sheet reflects a capital structure skewed heavily toward equity with modest use of debt. Key headline figures and derived metrics provide a snapshot of leverage, coverage and solvency.

• Total debt: CNY 266.92 million (short- and long-term borrowings aggregated)
• Total liabilities: CNY 1.10 billion (includes debt, payables, and other obligations)
• Shareholders' equity: CNY 2.70 billion
• Debt-to-equity ratio: 9.85% (Total debt / Total equity)
• Interest coverage ratio (Q1-Q3 2025): 26.59 (EBIT / Interest expense)

Interpretive notes and implications for investors:

• Low leverage: A 9.85% debt-to-equity ratio indicates limited reliance on borrowed funds relative to equity capital, reducing financial risk from interest and refinancing pressure.
• Strong interest coverage: An interest coverage ratio of 26.59 for the first three quarters of 2025 suggests operating earnings comfortably cover interest obligations, providing flexibility for investment or dividend policy.
• Liquidity and solvency context: Total liabilities of CNY 1.10 billion versus shareholders' equity of CNY 2.70 billion implies a solid equity buffer to absorb shocks; however, current and quick ratios (not shown here) should be checked for short-term liquidity.
• Strategic capacity: Low debt levels may enable Innuovo Technology to raise debt opportunistically for growth without stressing the balance sheet, but may also indicate conservative capital deployment that could impact return on equity.

For related corporate direction and values that frame capital allocation decisions, see: Mission Statement, Vision, & Core Values (2026) of Innuovo Technology Co., Ltd.

Innuovo Technology Co., Ltd. (000795.SZ) Liquidity and Solvency

• Current ratio (9/30/2025): 2.16 - suggests the company has more than twice the current assets to cover current liabilities.
• Quick ratio (9/30/2025): 1.24 - indicates sufficient near-cash assets to meet short-term obligations without relying on inventory liquidation.
• Cash & cash equivalents (9/30/2025): CNY 555.09 million - a strong cash buffer for working capital, capex, or strategic uses.
• Operating cash flow (first 3 quarters 2025): CNY 411.36 million - demonstrates healthy cash generation from core operations year-to-date.
• Free cash flow (first 3 quarters 2025): CNY 48.65 million - positive FCF after investments, signaling retained cash after capex.
• Net cash position (9/30/2025): CNY 488.17 million - net of debt, indicating the company is in a net creditor position.

Innuovo Technology Co., Ltd. (000795.SZ) - Valuation Analysis

Key valuation metrics as of December 5, 2025, and performance trailing figures relevant for investors.

• High P/E (45.13) signals market is pricing in significant growth or premium relative to current earnings (EPS CNY 0.183 through Q3 2025).
• P/B of 4.16 indicates the stock trades well above book value; investors should check asset composition and intangible-heavy balance sheet items.
• Market cap vs. EV parity (CNY 10.88bn vs CNY 10.57bn) suggests moderate net debt position-confirm net cash/debt on latest balance sheet.
• Dividend yield 1.39% is modest; income-focused investors may find yield below sector/market averages.

For broader context on company fundamentals, history and strategy, see: Innuovo Technology Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Innuovo Technology Co., Ltd. (000795.SZ) - Risk Factors

• Revenue trend: revenue declined 9.87% year-on-year in the first three quarters of 2025, indicating weakening sales momentum and potential market-share pressure.
• Profitability pressure: net profit decreased 3.16% year-on-year in the first three quarters of 2025, while gross and operating margins compressed.
• Margin compression: gross profit margin fell to 24.1% and operating profit margin dropped to 6.41% in the first three quarters of 2025, reducing the buffer against cost shocks.
• Cash flow deterioration: operating cash flow decreased to CNY 411.36 million in the first three quarters of 2025, constraining internal funding for capex, R&D or working capital.
• Rising leverage: debt-to-equity ratio increased to 9.85% as of September 30, 2025, raising solvency concerns if earnings continue to weaken.

Innuovo Technology Co., Ltd. (000795.SZ) - Growth Opportunities

• Planned investment: approximately CNY 424 million into a 5,000‑ton sintered NdFeB magnet production expansion project.
• Board approval: expansion approved at the company's ninth meeting of the tenth board of directors.
• Schedule: project commencement referenced to June 27, 2025 with an expected completion within 18 months (target completion date: December 27, 2026).

• Capacity impact: adding 5,000 tpa of sintered NdFeB can materially increase Innuovo's revenue mix toward higher‑margin permanent magnet products and reduce unit costs via scale.
• Technological uplift: expansion can be structured to incorporate advanced alloying, powder handling, and coating processes-enhancing product performance and yield.
• Market positioning: larger, modernized capacity supports long‑term contracts with EV and renewable OEMs, strengthening bargaining power in price and offtake terms.
• Supply chain resilience: onshore increased sintered NdFeB output helps mitigate import dependency and exposure to rare‑earth supply shocks.

• Capex allocation: CNY 424m is a meaningful capital expenditure-investors should monitor funding sources (internal cash, debt, or equity) and near‑term impact on leverage and cash flow.
• Revenue leverage: if utilization reaches industry benchmarks (e.g., 70-85% within 1-2 years), incremental topline and improved margins could be substantial given high unit value of NdFeB magnets.
• Execution risk: timeline (18 months) and ramp to stable operations will determine the realization of assumed benefits; construction, equipment procurement, and talent hiring are critical path items.